Pacira Biosciences Inc
NASDAQ:PCRX

Watchlist Manager
Pacira Biosciences Inc Logo
Pacira Biosciences Inc
NASDAQ:PCRX
Watchlist
Price: 26.02 USD 1.09% Market Closed
Market Cap: 1.1B USD

Intrinsic Value

The intrinsic value of one PCRX stock under the Base Case scenario is hidden USD. Compared to the current market price of 26.02 USD, Pacira Biosciences Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PCRX Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Pacira Biosciences Inc

Intrinsic Value History
Dive into the past to invest in the future

PCRX looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if PCRX is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PCRX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PCRX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Pacira Biosciences Inc.

Explain Valuation
Compare PCRX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PCRX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pacira Biosciences Inc

Current Assets 562.8m
Cash & Short-Term Investments 246.3m
Receivables 115.3m
Other Current Assets 201.1m
Non-Current Assets 734.8m
Long-Term Investments 20.3m
PP&E 191.7m
Intangibles 402.7m
Other Non-Current Assets 120.2m
Current Liabilities 107.1m
Accounts Payable 17.7m
Accrued Liabilities 89.4m
Non-Current Liabilities 463.3m
Long-Term Debt 376.7m
Other Non-Current Liabilities 86.6m
Efficiency

Free Cash Flow Analysis
Pacira Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Pacira Biosciences Inc

Revenue
716.8m USD
Cost of Revenue
-149.3m USD
Gross Profit
567.5m USD
Operating Expenses
-503.8m USD
Operating Income
63.6m USD
Other Expenses
-42.2m USD
Net Income
21.4m USD
Fundamental Scores

PCRX Profitability Score
Profitability Due Diligence

Pacira Biosciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Sustainable 3Y Average Operating Margin
hidden
Profitability
Score

Pacira Biosciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PCRX Solvency Score
Solvency Due Diligence

Pacira Biosciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Pacira Biosciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PCRX Price Targets Summary
Pacira Biosciences Inc

Wall Street analysts forecast PCRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCRX is 30.31 USD with a low forecast of 23.23 USD and a high forecast of 39.9 USD.

Lowest
Price Target
23.23 USD
11% Downside
Average
Price Target
30.31 USD
16% Upside
Highest
Price Target
39.9 USD
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Pacira Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PCRX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PCRX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PCRX stock?

The intrinsic value of one PCRX stock under the Base Case scenario is hidden USD.

Is PCRX stock undervalued or overvalued?

Compared to the current market price of 26.02 USD, Pacira Biosciences Inc is hidden .

Back to Top